Název instituce

ProQinase GmbH

Adresa ProQinase GmbH
Breisacher Str. 117
D-79106 Freiburg
Kontaktní web http://www.proqinase.com
Kontaktní email
Kontaktní telefon/fax Telefon: +49-761-206-1780 , Fax:  +49-761-206-1781
Komunitní servery
Oblasti působení
  • Molekulární terapeutické cíle
  • Molekulární biologie
ProQinase GmbH is a research division of the KTB Tumorforschungsgesellschaft mbH at the Tumor Biology Center Freiburg, Germany, and provides an Integrated Protein Kinase Technology Platform for preclinical drug development of protein kinase inhibitors. ProQinase offers its products and services to biotech and pharmaceutical companies. Currently, 200 highly active recombinant kinases are offered for sale and 300 kinases are available for in vitro testing services (HTS and selectivity profiling etc). Cellular and in vivo test systems including orthotopic tumour models allow further testing of lead compounds. A clinical biomarker analysis service supports the evaluation of clinical trials. In addition to its fee-for-service business ProQinase has several ongoing R&D programmes for the development of novel drugs for the treatment of cancer.
Pozice na mapě
Michael Kubbutat, Ph.D.
Head R&D, ProQinase GmbH

Michael Kubbutat obtained his PhD in Biology at the Medical University of Luebeck, Germany, where he studied the function of the proliferation marker Ki-67 in tumor cells. He started his postdoctoral fellowship at the Ludwig Institute for Cancer...
Přidej na TiskPřidej na OblíbenéPřidej na e-mailPřidej na FacebookPřidej na Twitter